Verapamil was developed as a calcium channel blocker for the treatment of hypertension, but it is also a substrate and inhibitor of P-glycoprotein, a mammalian drug efflux protein, and of transporter protein such as ATP-binding ABC efflux pump (34). This evidence concerns the gene ABCB1 and hypertensive disorder.